Search Results 1871-1880 of 21507 for platelets

  1. Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy - Mayo Clinic

    Patients with platelet count < 100 x109th/L. Patients with initial elevation of liver enzymes (AST or ALT) > 1.5 times above normal limit at baseline ...

  2. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial (FASTEST) - Mayo Clinic

    Known or suspected thrombocytopenia (unless current platelet count documented above 50,000/μL). Unfractionated heparin use with abnormal PTT. Pro-coagulant ...

  3. A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) - Mayo Clinic

    ... platelet-derived growth factor receptor alpha (PDGFRA) mutation, who has progressed on or was intolerant to at least 1 approved tyrosine kinase inhibitor ...

  4. Minority-inclusive Imaging Biomarker-based End of Therapy Trial for 177Lu-PSMA-617 - Mayo Clinic

    * Platelets ≥ 75,000/mm\^3 * Neutrophils ≥ 100/mm\^3 * Estimated glomerular filtration rate (eGFR) \< 50 mL/min \*body surface area (BSA) using Cockcroft ...

  5. Hemoglobin test - Mayo Clinic

    It measures the amount of a protein in red blood cells called hemoglobin. Hemoglobin carries oxygen to the body's organs and tissues when you breathe in. Then ...

  6. Publications - Sahil Gupta, M.B.B.S., M.D. - Mayo Clinic

    GPIbalpha is required for platelet-mediated hepatic thrombopoietin generation. Blood. 2018 Aug 9; 132 (6):622-634 Epub 2018 May 24. View PubMed; Venkatraman A ...

  7. Home Care Treatment With Oral Chemotherapy For Recurrent Or Metastatic Oral Cavity Cancer - Mayo Clinic

    Platelet count ≥100,000/mm3. Total bilirubin ≤1.5 x ULN. Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤3 x ULN (≤5 x ULN for patients ...

  8. Subharmonic Aided Pressure Estimation Of Portal Hypertension - Mayo Clinic

    ... Platelet Ratio Index (APRI) and FIB-4. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  9. A Study to Evaluate Obinutuzumab to Treat Immunosuppression-dependent or Immunosuppression/Treatment-resistant Focal Segmental Glomerulosclerosis - Mayo Clinic

    Thrombocytopenia with platelet count < 100'000. Any other disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding ...

  10. Neurology - Doctors - Mayo Clinic

    Boon, M.D.. Physiatrist; Electrodiagnostic Physician. Rochester, MN. Areas of focus: Injection, Platelet rich plasma injection, Rehabilitation therapy, Botox ...